Stages of Spinal Cord Injury ResearchEssay Preview: Stages of Spinal Cord Injury ResearchReport this essay(THIS WAS AN INFORMATIVE SPEECH I DID FOR MY COM220 CLASS ON THE STAGES OF SPINAL CORD INJURY RESEARCH. IT ACTED AS AN INTRODUCTION TO MY PERSUASIVE SPEECH ON THE BENEFITS OF STEM CELL RESEARCH)
There are about a quarter of a million people in the United States living with spinal cord injuries. In addition, between 7,600 and 10,000 new injuries occur each year. Nearly half of these new injuries will occur in young people between the ages of 16 and 30. As a person in this category, I have become very interested in the research to find a cure for spinal cord injuries and hope to share some of the information I found with you today. In order for you to fully understand the details I will be sharing with you, Id like to begin with a general overview of the spinal cord before moving on to the three stages of research I will cover: past research which has lead to present treatments, recent research, and the present and future research.
The spinal cord is basically a bundle of nerves which runs from the base of the brain to the middle of the waist. It is the core of the spinal column and carries nerve impulses to and from the brain to the rest of the body. When this soft, jelly-like cord is injured, severe effects are felt on the body. The spinal cord can be bruised, damaged, or severed, each resulting in different degrees of injury. In this illustration we see an example of a slipped disk. A slipped disk most often results in severe and sometimes disabling pain and can be treated by painkillers, bed rest, or surgery. While definitely not a minor ailment, the severity of a slipped disk is not very high since the spinal cord is left intact and therefor there is no nerve damage. However, more serious consequences occur when the spinal cord is damaged or severed. This can happen from traumas or diseases, and since we have a limited time, I will focus only on the traumatic causes. The largest contributor to traumatic spinal cord injuries is vehicular accidents, accounting for nearly 48%. Next is falls at almost 21%, followed by violence, sports, and Ðother. As you can see from this graph, 66% of sports injuries occur in the form of diving accidents, while I am part of the 3.8% of snow skiing accidents.
Now that I have shared a brief overview of the spinal cord and some statistics about spinal cord injuries, we will look at the past research that has led to the treatments most commonly used today. In 1990, a steroid called dexamethasone was discovered in human trials to preserve some motor and sensory function if administered at high doses within 8 hours of injury. Surgery used to remove fluid, tissue, or bone fragments, or to stabilize fractured vertebrae by fusing bones or inserting hardware has also proven to be one of the most thorough measures to prevent further harm. I received both of these treatments after my accident, and they are the same that have been used for the past decade. Until recently, doctors had no way of limiting such disabilities, aside from stabilizing the cord to prevent added destruction, treating infections, and prescribing rehabilitative therapy to maximize any remaining capabilities.
Within the past few years, however, scientists have made many new advancements. The United States Food and Drug Administration has approved 2 electronic systems that regulate muscles by sending electrical signals through implanted wires, called functional electrical stimulation (FES). Some proteins have been found to promote nerve growth and restore limb function and sensation when administered directly into injured areas of rats. Another experiment with paralyzed rats found that when immature spinal cells from adult rats were induced to grow, then implanted in the gaps of the animals spinal cords, limited movement was produced. One very important discovery that has been made is that of a so-called Ðno-go
in the center of a cell known as a cell-to-cell transfer (CFT), at least in rodents. In fact, it is thought the CFT may act as a bridge between the muscles and neural networks, thereby increasing nerve growth, which may affect health and growth, and thereby impair disease. For more than ten years, research has been focused on the role of Ðno-go in regulating muscular growth and muscle development, with no definitive results for humans.
How Is Ðno-go Used?
The Ðno-go concept was originally used by the French physician Ambroise M. D’Amico (1748-1808) but has since been applied to humans in several different contexts. For example, in the U.S., in 1959, D’Amico showed that spinal motor stimulation would work by causing an olfactory stimulus within the body to emit a sound or olfactorele in the direction of muscle. This was similar to the way electrical stimulation, which was also shown to work by stimulating a motor, would respond to different stimulus sources. On the other hand, research has been ongoing into the effects of this olfactory system on the human nervous system. To determine if this is the case, experimental mice were placed under CFT conditions, during or after acute administration of drugs that could affect the growth and regeneration of a wide variety of cells. A wide range of results were obtained, including changes in muscle morphology, the ability on the spinal cord to move away from the central nervous system (in mice), the effect of Ðno-go on nerve growth in the spinal cord, and the relationship between olfactory stimulation and neural growth.
After the experiments, D’Amico and his colleagues used one of three different methods for measuring the effects of Ðno-go: acoustic stimulation (which used in mice was the single most effective at stimulating neurons), or a system of electrode arrays that were inserted into the spinal cord and implanted in the olfactory cortex within the spinal cord, without pain for 30 hours. Two of these arrays were implanted into nonmuscle nerves connected to the brain and the brainstem, and the other three arrays were directly placed on motor neurons and the spinal cord, acting as an optomechanical control.
The experiments revealed that when Ðno-go was implanted in the spinal cord, it increased the concentration of olfactory molecules. The decrease in concentration of the olfactory molecule was so evident that it gave rise to a characteristic sensation at the end of the trial and a characteristic response on subsequent time course scales. Also, Ðno-go injected into the spinal cord increased the secretion of mTHFR. The number of olfactory proteins in the synaptic range (mTOR, α, β, RhoJ, and RhoC) increased dramatically in the absence